TNFSF13B and COVID-19: In addition, BAFF, but not APRIL, levels were increased more significantly in the sera of patients with severe COVID-19 than those in the sera of the non-severe group, suggesting robust B cell activation and corresponding high antibody response in patients with severe COVID-19 [50].